Description
The Comprehensive 2023 Gastroenterology Update
Harvard The Comprehensive 2023 Gastroenterology Update at Harvard University aims to provide participants with the most recent and cutting-edge strategies and practices in the field of gastroenterology. This initiative is intended to cover the recent advances that have occurred and the impact they have on practical approaches to clinical medicine and patient outcome. participants will have the opportunity to learn from recognized experts in the field of GI medicine and practicing clinicians who will share new information, methods, and guidelines.
Practical, Results-Driven Education
Highlights of the 2023 program include:
- Updated guidelines for the use of biologics in IBD
- Therapeutic drug monitoring in IBD treatment
- Updated guidelines for treatment of C. difficile infection
- Managing GI complications of immunotherapy
- Improved management of IBS and pelvic floor disorders
- Management of refractory GERD
- Expanded genetic testing options to diagnose hereditary GI cancer syndromes
- Management of fatty liver disease in 2023
- How to diagnose and manage cirrhosis
- How to improve your adenoma detection rate (ADR)
- Steps to ensure delivery of high-quality colonoscopic care
- Techniques to effectively control acute GI bleeding
- When FMT is indicated for treatment
- Impact of COVID on GI practice
- New strategies to treat common GI problems
- A comprehensive update of national guidelines
As new strategies, guidelines, and diagnostic and treatment options are presented, they are coupled with specific recommendations for incorporating these updates into your day-to-day work.
Education to Optimize Your Patient Outcomes
The evidence-based recommendations provided in this program cover:
- IBD
- GI Complications of Immunotherapy
- Microscopic Colitis
- Fatty Liver
- Barrett’s Esophagus
- Eosinophilic Esophagitis
- C. difficile Colitis
- Alcohol-Related Liver Disease
- Autoimmune Hepatitis
- IBS
- Refractory GERD
- Pelvic Floor Disorders
- Acute Pancreatitis
- Chronic Pancreatitis
- Celiac Disease
- GI Bleeding
- High Risk for Colorectal Cancer
Recent Advances and Innovations
Clinicians can rely on this program for education on:
- Biological therapies for IBD: how to choose which agent to start with? How to monitor during treatment? What is the role for therapeutic drug monitoring? When to switch? What new agents are now available?
- Managing refractory pouchitis
- GI complications of immunotherapy — a common and heterogeneous disorder: how to approach and treat effectively?
- Eosinophilic esophagitis: how to decide between drug therapy and dietary therapy?
- The stool microbiome: understanding the science behind clinical applications
- Celiac disease: making sense of the multiple serologic tests—new therapeutic strategies are on the horizon
- Adenoma detection rates: critical to measure and how to incorporate strategies to increase your rate
Key Benefits:
- State-of-the-art GI Strategy: The program guarantees that participants are familiar with the most recent state-of-the-art tactics in gastroenterology. This includes improvements in diagnostic methods, treatment options, and management methods.
- Clinical Practice Updates: participants will receive information on the most recent practices in gastroenterology, these will include the most effective evidence-based suggestions. These enhancements will facilitate increased decision making and improve patient care.
- Insights from National Experts include: The program features celebrated GI experts and accomplished clinicians who will share their knowledge and provide important information about the current state of affairs and future potential in the field.
- Comprehensive Envolvement: The course involves a variety of topics in gastroenterology that ensure that participants receive a comprehensive update on all of the interest and relevance areas.
Learning Goals:
- Keep Up with the Advances: participants will become aware of recent advances in gastroenterology and will understand the implications of these advances for clinical practice.
- Increase Clinical Effectiveness: The program will assist participants in improving their clinical effectiveness by utilizing the most recent scientifically-based guidelines, practices, and methods of treatment.
- Increase Patient Outcomes: By staying abreast of the latest strategies and practical procedures, participants will have the capacity to increase the quality of care and provide superior service to patients.
Target audience:
- The Complete 2023 Gastroenterology Update is intended for gastroenterologists, doctors, and other healthcare professionals involved in the treatment of patients with disorders of the gastrointestinal system. This includes students in both academic and non- academic settings who want to expand their knowledge and abilities in the field.
- By participating in this program, participants will receive important information, updates, and practical knowledge that will enhance their clinical practice in the field of gastroenterology. The course focuses on evidence-based approaches and aims to increase the efficiency of patients through the incorporation of recent advances in the field.
Schedule
Monday, June 12, 2023
| 8:30am to 8:35am | WelcomeDaniel Chung, MD | |
| 8:35am to 9:20am | Which Initial Therapy to Choose for Crohn’s and UC?Joshua Korzenik, MD | |
| 9:20am to 10:00am | Management of Severe UC and Pouch-Related ComplicationsAshwin Ananthakrishnan, MD, MPH | |
| 10:00am to 10:35am | IBD in Pregnancy and the ElderlySonia Friedman, MD | |
| 10:35am to 10:50am | Panel Q&ADrs. Ananthakrishnan, Friedman, and Korzenik | |
| 10:50am to 11:05am | Break | |
| 11:05am to 11:40am | WORKSHOP 1: Cutaneous Manifestations of IBDDaniela Kroshinsky, MD | |
| 11:40am to 12:20pm | Therapeutic Drug Monitoring in IBDAdam Cheifetz, MD | |
| 12:20pm to 12:35pm | Panel Q&ADrs. Cheifetz and Kroshinsky | |
| 12:35pm to 1:45pm | Break | |
| 1:45pm to 2:15pm | How to Manage Microscopic ColitisHamed Khalili, MD | |
| 2:15pm to 2:45pm | GI Complications of ImmunotherapyMichael Dougan, MD | |
| 2:45pm to 3:00pm | Panel Q&ADrs. Dougan and Khalili | |
| 3:00pm to 3:15pm | Break | |
| 3:15pm to 3:50pm | What’s New in Hereditary GI CancersDaniel Chung, MD | |
| 3:50pm to 4:25pm | WORKSHOP 2: CRC Screening and How to Improve Your ADRRamona Lim, MD | |
| 4:25pm to 5:00pm | Chemoprevention of CRC: What Should You Recommend?Andrew Chan, MD, MPH | |
| 5:00pm to 5:15pm | Panel Q&ADrs. Chan, Chung, and Lim |
Tuesday, June 13, 2023
| 8:30am to 9:05am | Barrett’s Esophagus: Whom and How to Treat?Douglas Pleskow, MD | |
| 9:05am to 9:40am | Esophageal Motility Disorders Made EasyBarbara Nath, MD | |
| 9:40am to 10:15am | Management of Refractory GERDNorman Nishioka, MD | |
| 10:15am to 10:30am | Panel Q&ADrs. Nath, Nishioka, and Pleskow | |
| 10:30am to 10:45am | Break | |
| 10:45am to 11:20am | Comprehensive Approach to Eosinophilic EsophagitisWalter Chan, MD | |
| 11:20am to 12:10pm | Celiac Disease and Gluten Sensitivity: 2023 Practitioner UpdatesCiaran Kelly, MD | |
| 12:10pm to 12:25pm | Panel Q&ADrs. Chan and Kelly | |
| 12:25pm to 1:30pm | Break | |
| 1:30pm to 2:00pm | Optimizing the Management of GastroparesisBraden Kuo, MD | |
| 2:00pm to 2:40pm | Making the Diagnosis of IBSKyle Staller, MD | |
| 2:40pm to 3:20pm | Modern Strategies to Treat IBSJohanna Iturrino Moreda, MD | |
| 3:20pm to 3:35pm | Panel Q&ADrs. Iturrino Moreda, Kuo, and Staller | |
| 3:35pm to 3:50pm | Break | |
| 3:50pm to 4:20pm | How to Evaluate Small Intestinal Bacterial OvergrowthJudy Nee, MD | |
| 4:20pm to 4:50pm | WORKSHOP 3: Systematic Approaches to Pelvic Floor DisordersMeghan Markowski, PT, DPT | |
| 4:50pm to 5:05pm | Panel Q&ADrs. Markowski and Nee |
Wednesday, June 14, 2023
| 8:30am to 9:05am | Cholestatic Liver Diseases: What’s New in PBC and PSCDaniel Pratt, MD | |
| 9:05am to 9:40am | Update on Autoimmune HepatitisAlan Bonder, MD | |
| 9:40am to 10:10am | WORKSHOP 4: How to Approach Drug-Induced Liver Injury (DILI)Michael Curry, MD | |
| 10:10am to 10:25am | Panel Q&ADrs. Bonder, Curry, and Pratt | |
| 10:25am to 10:40am | Break | |
| 10:40am to 11:20am | Alcohol-Associated Liver DiseaseGyongyi Szabo, MD, PhD | |
| 11:20am to 11:50am | The Management of NAFLDKathleen Corey, MD | |
| 11:50am to 12:05pm | Panel Q&ADrs. Corey and Szabo | |
| 12:05pm to 1:05pm | Break | |
| 1:05pm to 1:40pm | WORKSHOP 5: How to Work Up a Liver LesionKarin Andersson, MD | |
| 1:40pm to 2:15pm | Diagnosis and Routine Management of CirrhosisMichelle Lai, MD | |
| 2:15pm to 2:55pm | End-Stage Liver Disease and Management of Portal HypertensionAnna Rutherford, MD | |
| 2:55pm to 3:10pm | Panel Q&ADrs. Andersson, Lai, and Rutherford | |
| 3:10pm to 3:25pm | Break | |
| 3:25pm to 4:00pm | Best Management Strategies in Acute PancreatitisDavid Jin, MD, MPH | |
| 4:00pm to 4:35pm | Updates in Chronic PancreatitisSunil Sheth, MD | |
| 4:35pm to 5:10pm | Controversies in the Management of Cystic Lesions of the PancreasCarlos Fernandez-del Castillo, MD | |
| 5:10pm to 5:25pm | Panel Q&ADrs. Fernandez-del Castillo, Jin, and Sheth |
Thursday, June 15, 2023
| 8:30am to 9:15am | WORKSHOP 6: Tips for Identifying and Removing Colon PolypsTyler Berzin, MD | |
| 9:15am to 9:45am | Quality Measures for Colonoscopy: What’s New and Why It MattersMandeep Sawhney, MD | |
| 9:45am to 10:00am | Panel Q&ADrs.Berzin and Sawhney | |
| 10:00am to 10:15am | Break | |
| 10:15am to 10:50am | Endoscopy and the Anticoagulated PatientKunal Jajoo, MD | |
| 10:50am to 11:30am | Acute GI Bleeding and Other GI EmergenciesLinda Lee, MD | |
| 11:30am to 12:05pm | WORKSHOP 7: Challenging Case Presentations in GIDouglas Horst, MD | |
| 12:05pm to 12:20pm | Panel Q&ADrs. Horst, Jajoo, and Lee | |
| 12:20pm to 1:30pm | Break | |
| 1:30pm to 2:00pm | New Insights into the Gut Microbiome and DiseaseRamnik Xavier, MD | |
| 2:00pm to 2:40pm | COVID in the GI TractWalter Chan, MD, MPH | |
| 2:40pm to 3:20pm | What’s New in C. difficile ColitisJessica Allegretti, MD, MPH | |
| 3:20pm to 3:35pm | Panel Q&ADrs. Allegretti, Chan, and Xavier |
